Synthetic modified RNA and uses thereof
AssigneeIcahn School of Medicine at Mount Sinai
InventorsLior Zangi, Yoav Hadas, Nishat Sultana
Life of this patent
Estimating the term…
Abstract
The present application relates to a nucleic acid molecule comprising a first nucleic acid sequence comprising at least a portion of a 5′ untranslated region (5′ UTR) of a carboxylesterase gene and a second nucleic acid sequence encoding a protein of interest, where the second nucleic acid sequence is heterologous to and operatively coupled to the first nucleic acid sequence. Also disclosed are methods of expressing a protein of interest in a target cell, methods of treating subject for cardiac ischemia or hepatic ischemia, and methods of identifying a nucleic acid sequence capable of selectively enhancing translation of a heterologous protein of interest in a target cell.
Claims19
A nucleic acid molecule comprising:
- a first nucleic acid sequence comprising at least a portion of a 5′ untranslated region (5′ UTR) of a carboxylesterase gene, wherein the carboxylase is a carboxylase 1D (Ces1D) or a carboxylesterase 1 (CES1), and
- a second nucleic acid sequence encoding a protein of interest, wherein the second nucleic acid sequence is heterologous to and operatively coupled to the first nucleic acid sequence.
Dependencies are inferred from the claim text.